In 2016, the European market for GERD drugs and devices have been accounted as the largest market worldwide owing to the existence of a large number of patients suffering from GERD in this region. This market has been predicted to grow with 0.93% CAGR during the forecasted years of 2019-2027. The chances of GERD among patients coming for diagnosis at least once per week is in the range of 8.8–25.9 % in Europe.

EUROPE GERD DRUGS AND DEVICES MARKET FORECAST 2019-2027

Request free sample

Report Summary

The chances of GERD among patients coming for diagnosis at least once per week is in the range of 8.8–25.9 % in Europe. Associations like European Medicines Agency (EMA), Federal Institute for Drugs and Medical Devices, German Society of Gastroenterology, Digestive and Metabolic Diseases, etc. are the key regulatory bodies that are spreading awareness about GERD and other acid-associated maladies. This level of awareness is promoting the growth of the said market in Europe.

Germany and Spain are found to be the largest contributors to the European GERD drugs and devices market. Nevertheless, it stands second behind Japan, in terms of life expectancy at birth and at 65 years of age. Disadvantageous causes like poorly treated or misdiagnosed conditions, a high share of out-of-pocket spending and fewer numbers of health professionals are still enhancing the rate of GERD occurrence.

To enhance their product portfolios, key market players are rigorously developing newer drugs and expanding their bases in each region. They are Abbott Laboratories, AstraZeneca, Ausch Health (Formerly Valeant Pharmaceuticals International, Inc.), Boston Scientific Corporation, Cempra Inc. (Merged with Melinta), Daewoong Co. Ltd., Eisai Inc., Glaxosmithkline, Ironwood Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co. Inc., Novartis, Pfizer, Inc., RaQualia Pharma Inc. and Takeda Pharmaceuticals Company Limited.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
RESEARCH METHODOLOGY
- SOURCES OF DATA
  - SECONDARY DATA
  - PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
  - ANTACIDS DRUG CLASS HOLDS THE LARGEST MARKET SHARE
  - BRAVO SYSTEM DEVICES ARE WIDELY USED

MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
  - GROWING TREND OF SELF-MEDICATION
  - INCREASING AWARENESS ABOUT GERD
  - INCREASING OCCURRENCE OF GERD DISORDERS
  - CHANGES IN LIFESTYLE
- MARKET RESTRAINTS
  - PATENT EXPIRY
  - ADVERSE EFFECT OF PROTON PUMP INHIBITORS AND OTHER DRUGS
  - PROTON PUMP INHIBITOR RESISTANCE
- MARKET OPPORTUNITIES
  - INCREASED PRACTICE OF GENERICS AND OTC DRUGS
  - COST-EFFECTIVE OTC DRUGS
  - OVERUSE OF MEDICATION AND DIETARY SUPPLEMENTS
- MARKET CHALLENGES
  - USE OF COMPLEMENTARY AND ALTERNATIVE TREATMENTS
  - PROBABILITY OF BUYING COUNTERFEIT DRUGS
- MARKET BY DRUGS DOSAGE FORM
- MARKET BY ROUTE OF ADMINISTRATION OF DRUGS
MARKET BY DRUGS AND DEVICES
- DRUG CLASS
  - ANTACIDS
  - H2 RECEPTOR BLOCKERS
  - PROTON PUMP INHIBITORS (PPI)
  - PRO-KINETIC AGENTS
- DEVICES
  - DIGITRAPPER
  - BRAVO SYSTEM
  - STRETTA
  - LINX REFLUX MANAGEMENT SYSTEM
  - MUSE (MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER) SYSTEM
  - OTHER DEVICES

KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
  - THREAT OF NEW ENTRANTS
  - THREAT OF SUBSTITUTE
  - BARGAINING POWER OF SUPPLIERS
  - BARGAINING POWER OF BUYERS
  - THREAT OF COMPETITIVE RIVALRY
- PIPELINE DRUGS
- REGULATORY FRAMEWORK
- PATENT ANALYSIS
- OPPORTUNITY MATRIX
GEOGRAPHICAL ANALYSIS
- EUROPE
  - THE UNITED KINGDOM
  - GERMANY
  - FRANCE
  - ITALY
  - SPAIN
  - REST OF EUROPE

COMPETITIVE LANDSCAPE
- MARKET SHARE ANALYSIS
- COMPANY PROFILES
  - ABBOTT LABORATORIES.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - ASTRAZENECA
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - BAUSCH HEALTH (FORMERLY VALEANT PHARMACEUTICALS INTERNATIONAL, INC.)
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - BOSTON SCIENTIFIC CORPORATION
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - CEMPRA INC. (MERGED WITH MELINTA)
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - DAEWOONG CO. LTD.
    - COMPANY PROFILES
    - PRODUCT PORTFOLIO
    - STRATEGIC INITIATIVES
  - EISAI INC
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - GLAXOSMITHKLINE
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - IRONWOOD PHARMACEUTICALS, INC.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - JOHNSON & JOHNSON
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - MERCK & CO., INC.
    - COMPANY PROFILES
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - NOVARTIS
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - PFIZER, INC.
    - COMPANY PROFILES
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES
  - RAQUAL IA PHARMA INC.
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - STRATEGIC INITIATIVES
  - TAKEDA PHARMACEUTICALS COMPANY LIMITED
    - COMPANY OVERVIEW
    - PRODUCT PORTFOLIO
    - SCOT ANALYSIS
    - STRATEGIC INITIATIVES

LIST OF TABLES

TABLE 1 EUROPE GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

TABLE 2 EUROPE GERD DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 3 EUROPE DRUG CLASS MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 4 EUROPE DRUG CLASS MARKET 2019-2027 ($ MILLION)

TABLE 5 EUROPE ANTACIDS MARKET 2019-2027 ($ MILLION)

TABLE 6 EUROPE H2 RECEPTOR BLOCKERS MARKET 2019-2027 ($ MILLION)

TABLE 7 EUROPE H2 RECEPTOR BLOCKERS MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 8 EUROPE PROTON PUMP INHIBITORS (PPI) MARKET 2019-2027 ($ MILLION)

TABLE 9 EUROPE PROTON PUMP INHIBITORS (PPI) MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 10 EUROPE PRO-KINETIC AGENTS MARKET 2019-2027 ($ MILLION)

TABLE 11 EUROPE DEVICES MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 12 EUROPE DEVICES MARKET 2019-2027 ($ MILLION)

TABLE 13 EUROPE DIGITRAPPER MARKET 2019-2027 ($ MILLION)

TABLE 14 EUROPE BRAVO SYSTEM MARKET 2019-2027 ($ MILLION)

TABLE 15 EUROPE STRETTA (MEDERITHERAPEUTICS) MARKET 2019-2027 ($ MILLION)

TABLE 16 EUROPE LINX® REFLUX MANAGEMENT SYSTEM (TORAX MEDICAL) MARKET 2019-2027 ($ MILLION)

TABLE 17 EUROPE MUSE™ (MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER) SYSTEM MARKET 2019-2027 ($ MILLION)

TABLE 18 EUROPE OTHER DEVICES MARKET 2019-2027 ($ MILLION)

TABLE 19 EUROPE GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

TABLE 20 EUROPE GERD DRUGS AND DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE 1 EUROPE GERD DRUGS AND DEVICES MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

FIGURE 2 EUROPE GERD DRUGS AND DEVICES MARKET SHARE BY DRUGS AND DEVICES 2017 & 2027 (%)

FIGURE 3 PORTER’S FIVE FORCE MODEL

FIGURE 4 EUROPE GERD DRUGS AND DEVICES MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 5 THE UNITED KINGDOM GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 6 GERMANY GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 7 FRANCE GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 8 ITALY GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 9 SPAIN GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 10 REST OF EUROPE GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 11 GERD PPIS DRUGS PROVIDER COMPANY MARKET SHARE 2017 (%)

Segmentation

GEOGRAPHICAL ANALYSIS
- EUROPE
  - THE UNITED KINGDOM
  - GERMANY
  - FRANCE
  - ITALY
  - SPAIN
  - REST OF EUROPE

MARKET BY DRUGS AND DEVICES
- DRUG CLASS
  - ANTACIDS
  - H2 RECEPTOR BLOCKERS
  - PROTON PUMP INHIBITORS (PPI)
  - PRO-KINETIC AGENTS
- DEVICES
  - DIGITRAPPER
  - BRAVO SYSTEM
  - STRETTA
  - LINX REFLUX MANAGEMENT SYSTEM
  - MUSE (MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER) SYSTEM
  - OTHER DEVICES